Detalles de la búsqueda
1.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer
; 126(9): 1264-1270, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992255
2.
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE Trial.
Clin Colorectal Cancer
; 18(1): e69-e73, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30415988
Resultados
1 -
2
de 2
1
Próxima >
>>